Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
8940 N. Wood Sage Rd | Peoria, IL 61615-7822
